UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug
March 27, 2023 at 11:28 AM EDT
UNITY Biotechnology Inc(NASDAQ: UBX) announced results from Part A of the Phase 2 ENVISION study of UBX1325 in patients with ...